These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24671247)

  • 1. [Molecular lymph node staging in prostate and bladder cancer].
    Heck MM; Retz M; Nawroth R
    Urologe A; 2014 Apr; 53(4):484-90. PubMed ID: 24671247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy.
    Herr HW
    Urology; 2003 Jan; 61(1):105-8. PubMed ID: 12559278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
    Hakimi AA; Ghavamian R
    Urol Clin North Am; 2011 Nov; 38(4):407-18, v. PubMed ID: 22045172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sentinel lymph node dissection in prostate cancer. Experience after more than 800 interventions].
    Weckermann D; Hamm M; Dorn R; Wagner T; Wawroschek F; Harzmann R
    Urologe A; 2006 Jun; 45(6):723-7. PubMed ID: 16586052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Pathology Findings in Patients Who Have Undergone Radical Cystectomy/Cystoprostatectomy With Extended Versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder: A Contemporary Analysis.
    Kagan J; Alemozaffar M; Carthon B; Osunkoya AO
    Int J Surg Pathol; 2021 Apr; 29(2):150-154. PubMed ID: 32573301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostate and bladder cancer: detection of disseminated tumor cells in bone marrow].
    Nawroth R; Weckermann D; Retz M
    Urologe A; 2014 Apr; 53(4):514-8. PubMed ID: 24671250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: patterns of initial transitional cell recurrence in patients after cystectomy.
    Zaghloul MS
    J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of radical cystoprostatectomy in men with bladder cancer infiltrating prostate versus co-existing prostate cancer: a research study.
    Bryniarski P; Fryczkowski M; Pawlaczek P; Pliszek K; Prokopowicz G; Kaletka Z; Paradysz A
    BMC Urol; 2010 Sep; 10():16. PubMed ID: 20860834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Clin Cancer Res; 2018 May; 24(10):2342-2349. PubMed ID: 29463560
    [No Abstract]   [Full Text] [Related]  

  • 14. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy.
    Rais-Bahrami S; Tracht JP; McIntosh ER; Lai WS; Gordetsky JB
    Int J Surg Pathol; 2017 Feb; 25(1):12-17. PubMed ID: 27388198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases.
    Martínez-Piñeiro L; Rios E; Martínez-Gomariz M; Pastor T; de Cabo M; Picazo ML; Palacios J; Perona R
    Eur Urol; 2003 Apr; 43(4):342-50. PubMed ID: 12667714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.